Pediatrics Doctors in Arroyo Grande, CA Accepting Medicare

4 Pediatrics doctors found. Showing 1 - 4

Roberta Joy Hayertz, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 912 Printz Rd, Arroyo Grande, CA 93420 Phone: 805-473-0297

Dr. Jeffrey S. Thompson, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 260 Station Way, Suite D, Arroyo Grande, CA 93420 Phone: 805-473-2828    Fax: 805-473-0149

Dr. Evelyn Mary Boyle, MD., FAAP Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 336 S Halcyon Rd, Arroyo Grande, CA 93420 Phone: 805-481-3658

William S. Morgan, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 154 Traffic Way, Arroyo Grande, CA 93420 Phone: 805-473-3262    Fax: 805-473-3707

News Archive

Ampio finalizes negotiations to acquire DMI BioSciences

Ampio Pharmaceuticals, Inc. today announced it has finalized negotiations with the directors of DMI BioSciences, Inc. (DMI) to acquire DMI BioSciences, Inc. This acquisition will give Ampio access to all rights, royalties and patents associated with DMI's major assets, drugs for male sexual dysfunction including premature ejaculation (PE) and combination drugs to treat premature ejaculation and erectile dysfunction (ED).

Workshop to help physicians and clinicians increase job satisfaction and prevent burnout

On Saturday, May 11, the Center for Mindfulness at University of California, San Diego School of Medicine is hosting a workshop to help physicians and clinicians increase job satisfaction and prevent burnout. The program will show participants how to incorporate the concept of mindfulness into their daily clinical practice with the long-term goal of enhancing patient-centered care and physician well-being through compassionate communication.

EMA approves CTI's Pixuvri Pediatric Investigation Plan for lymphoid malignancies and solid tumors

Cell Therapeutics, Inc. ("CTI") announced today that the European Medicines Agency ("EMA") approved CTI's Pixuvri (pixantrone dimaleate) Pediatric Investigation Plan ("PIP") for the treatment of lymphoid malignancies and solid tumors in children between the ages of six months and 18 years. Previously, the Pediatric Committee (the "PDCO") of the EMA adopted an opinion agreeing to the PIP and a deferral of the initiation of the clinical studies until after the drug receives EMA approval.

Wellstar International update on the Duke Study for predicting nosocomial pressure ulcers

The study was designed to determine that long-wave infrared imaging can be used to identify skin temperature changes associated with underlying tissue changes. We wanted to determine if the use of Long Wave infrared imaging is as effective as the Braden Score in predicting nosocomial pressure ulcers.

Read more Medical News

› Verified 5 days ago